Contact
Please use this form to send email to PR contact of this press release:
CYduct Diagnostics Granted Patent for Precision Medicine-Based Breast Cancer Risk Assessment Test
TO:
Elise Grubb
CYduct Diagnostics
+1 800-388-6445